On August 17, AXT Inc rose 5.07% in pre-market trading, trading at approximately $85.70/share, with turnover of $5.28 million. The stock continued its recent recovery trajectory as the market digests the Q2 earnings beat and indium phosphide supply-demand tightness.

AXT reported Q2 adjusted EPS of $0.19, beating the consensus estimate of $0.07 by over 171%. Revenue surged 165% year-over-year to $47.6 million, far exceeding the $34.1 million estimate. Indium phosphide substrate revenue reached a record $30.7 million in a single quarter, while adjusted gross margin leapt from 8.2% a year ago to 45.0%. Management characterized the quarter as a business inflection point rather than a one-quarter step-up. Wedbush maintained its outperform rating, noting that the AI-fueled opportunity appears still in its early innings.

At the industry level, the global indium phosphide substrate supply-demand gap exceeds 70%, with AI data center demand continuing to drive fundamental improvement expectations. On July 31, the stock surged nearly 28% following the earnings release, and has since sustained upward momentum on post-earnings reassessment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)